Psychopharmacology in HIV-positive patients: Research perspectives

Benedetto Vitiello, Ellen S. Stover

Research output: Contribution to journalReview articlepeer-review

Abstract

Psychotropic medications play an important role in the treatment of human immunodeficiency virus (HIV)-positive subjects suffering from neuropsychiatric disorders or other acquired immunodeficiency syndrome (AIDS)-related symptomatology. The quality of life of these patients can be significantly improved by the appropriate use of these agents. Various aspects of psychopharmacology that are relevant to HIV-positive patients include assessment of efficacy, tolerability, drug-drug interactions, and effects on cognition. These topics need further investigation and require focused research efforts. This report highlights current research needs and presents specific recommendations that emerged at a recent meeting on psychopharmacology for HIV-positive patients organized by the National Institute of Mental Health (NIMH).

Original languageEnglish (US)
Pages (from-to)293-297
Number of pages5
JournalPsychopharmacology bulletin
Volume32
Issue number3
StatePublished - Nov 12 1996

Keywords

  • HIV-positive
  • psychopharmacology

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Psychopharmacology in HIV-positive patients: Research perspectives'. Together they form a unique fingerprint.

Cite this